Company expects H1 to be a disaster. 1 - they flagged this in Nov18 2 - they only recently introduced new products but PAT will be impacted by ~$13m 3 - SAMR hasn't and may never eventuate 4 - no announcements upping sales forecasts 5 - they lost market share to A2M and Nestle 6 - Big institutions keep shorting this like no tomorrow (e.g. last week or so) 7 - Management appears happy to wait to deliver a sour report come 27 Feb
P/E is at best 35 in my opinion, which is roughly 5 cheaper than A2M but the BAL is going backwards and A2M thriving.
Good luck with your long positions. I give you my insights, take it or disregard it.
